US secures almost entire world stock of Covid-19 drug Remdesivir

The Donald Trump administration has secured nearly the entire world stock of antiviral drug remdesivir from US-based Gilead Sciences for the next three months, leaving hardly any stock of the key Covid-19 drug for the rest of the world.

from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/31Ixs5s